Cullinan Oncology

$44.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.28 (+2.96%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CGEM and other stocks, options, and ETFs commission-free!

About CGEM

Cullinan Oncology, Inc. Common Stock, also called Cullinan Oncology, is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA. The listed name for CGEM is Cullinan Oncology, Inc. Common Stock.

CEO
Owen Patrick Hughes
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2016
Market Cap
2.22B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
273.61K
High Today
$46.12
Low Today
$37.55
Open Price
$43.70
Volume
299.58K
52 Week High
$53.90
52 Week Low
$27.01

CGEM Earnings

Q4 FY20
Estimated
— per share
Actual
Expected Mar 19, Pre-Market

You May Also Like

MYI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure